SphereBio is redefining the landscape of single-cell analysis with its groundbreaking picodroplet microfluidic technology. As a global innovator, SphereBio delivers next-generation tools that accelerate biologics discovery and empower scientists with unmatched precision and scalability. Now available in India, these advanced platforms are designed not just to follow innovation but to lead it.
SphereBio's single-cell technology platform supports transformative applications in cellular biology and biotherapeutic development:
Accelerate selection of high-producing clones with ensured monoclonality and viability.
Screen millions of cells rapidly to identify rare, high-affinity antibody-producing clones.
Precisely isolate and verify engineered cells based on function and expression levels.
Enable functional screening of therapeutic cells to ensure efficacy and safety.
Optimize synthetic constructs by evaluating expression and performance at single-cell level.
SphereBio’s integrated platform ensures uniform, high-quality single-cell analysisboosting confidence in identifying hits, rare events, or engineered variants at scale.
Automated systems for high-throughput single-cell sorting, dispensing, imaging, and analysisideal for screening millions of cells efficiently.
Validated reagent kits for antibody discovery, cell therapy, and synthetic biology applicationsensuring consistency and accuracy across workflows.
Cartridges and chemicals designed for seamless operation with instrumentsminimizing variability and maximizing productivity.
Pioneering single-cell solutions to accelerate next-generation biologics and research.
Screen millions of individual cells rapidly with reliable precision.
All-in-one platform combining sorting, dispensing, imaging, and analysis.
Detect rare events and subtle phenotypic differences with confidence.
Adaptable for antibody discovery, cell therapy, and synthetic biology.